Glucocorticoid receptor polymorphism in patients with asthma and chronic obstructive pulmonary disease in Venezuela
Keywords:
Chronic obstructive pulmonary disease (COPD), asthma, glucocorticoidsAbstract
Asthma and chronic obstructive pulmonary disease (COPD) are diseases characterized by airflow obstruction and chronic inflammation and appear as a result of the interaction of different genes with multiple environmental elements. Inhaled glucocorticoids are used in the management of asthma and COPD, but some patients show little response to these medications; this individual variability in drug response may have a genetic basis. Some polymorphisms in the glucocorticoid receptor gene have been studied that could determine the appearance of these pathologies and the response to treatment. Objectives: To determine the association of BclI polymorphism with the development of asthma and chronic obstructive pulmonary disease. Methods: We studied 100 patients with asthma, 100 patients with COPD, and 100 Venezuelan mestizo controls. Genotypic characterization of Glucocorticoid Receptor +647 G/C was performed by Polymerase Chain Reaction technique and subsequent digestion of amplicons by BclI enzyme. Results: Significant differences were found between the two groups of patients and the control individuals, being observed a higher frequency of the homozygous GG genotype in patients with asthma with respect to patients with COPD (OR=10,5238; IC95%:4,7801-23,1688) and the control individuals (OR=16,3061; IC95%:6,5393-40,6601) and a lower frequency of the heterozygous GG genotype in patients with asthma.
Downloads
References
Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. (2008)Mar;8(3):183-92.
Guerra S. Asthma and chronic obstructive pulmonary disease. Curr Opin Allergy Clin Immunol. (2009) Oct;9(5):409-16.
Cosío BG, Fiorentino F, Scrimini S. Chronic obstructive pulmonary disease and asthma.Arch Bronconeumol.(2010); 46 Suppl 8:2-7.
Von Mutius E. Influences in allergy: epidemiology and the environment. J Allergy Clin Immunol (2004); 113:373-9
Menezes AM, Pérez-Padilla R, Jardín J, Muiño A, López M, Valdivia G et al. Chronic obstructive pulmonary disease in five Latin American cites (The PLATINO study): a prevalence study.
Lancet.(2005)Nov 26; 366(9500):1875-81. Marwick JA, Adcock IM, Chung KF. Overcoming reduced glucocorticoid sensitivity in airway disease: molecular mechanisms and therapeutic approaches. Drugs.( 2010 )May 28; 70(:929-48.
Fleury I, Beaulieu P, Primeau M, Labuda D, Sinnett D, Krajinovic M. Characterization of the BclI Polymorphism in the Glucocorticoid Receptor Gene. Clin Chemistry (2003); 49(9):1528-31.
Corvol H, Nathan N, Charlier C, Chadelat K, Le Rouzic P, Tabary O et al. Glucocorticoid receptor gene polymorphisms associated with progression of lung disease in young patients with cystic fibrosis. Respir Res (2007); 8:88-96.
Panek M, Pietras T, Antczak A, Górski P, Kuna P, Szemraj J. The role of functional single nucleotide polymorphisms of the human glucocorticoid receptor gene NR3C1 in Polish patients with bronchial asthma. Mol Biol Rep. 2012 Apr; 39(4):4749-57.
Rogausch A, Kochen MM, Meineke C, Hennig J. Association between the BclI glucocorticoid receptor polymorphism and smoking in a sample of patients with obstructive airway disease. Addict Biol.2007 Mar; 12(1):93-9.
Schwabe K, Vacca G, Dück R, Gillissen A. Glucocorticoid receptor gene polymorphisms and potential association to chronic obstructive pulmonary disease susceptibility and
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
